Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen.
about
Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaIdentification and characterization of a novel Plasmodium falciparum adhesin involved in erythrocyte invasionValidation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approachPlasmoSEP: Predicting surface-exposed proteins on the malaria parasite using semisupervised self-training and expert-annotated dataComparative Proteomics and Functional Analysis Reveal a Role of Plasmodium falciparum Osmiophilic Bodies in Malaria Parasite TransmissionMotility precedes egress of malaria parasites from oocystsImmunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidateAsymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand.Antigenicity and immunogenicity of PvRALP1, a novel Plasmodium vivax rhoptry neck protein.Characterization of Plasmodium vivax Early Transcribed Membrane Protein 11.2 and Exported Protein 1A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein InteractionsEnhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.Vaccine candidate discovery for the next generation of malaria vaccines.The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax.A Toxoplasma gondii Ortholog of Plasmodium GAMA Contributes to Parasite Attachment and Cell Invasion.Identification of a reticulocyte-specific binding domain of Plasmodium vivax reticulocyte-binding protein 1 that is homologous to the PfRh4 erythrocyte-binding domain.Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development.Progress and prospects for blood-stage malaria vaccinesRALP1 is a rhoptry neck erythrocyte-binding protein of Plasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigen.Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status.Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population.Application of wheat germ cell-free protein expression system for novel malaria vaccine candidate discovery.Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates.Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.PvGAMA reticulocyte binding activity: predicting conserved functional regions by natural selection analysisA male gametocyte osmiophilic body and microgamete surface protein of the rodent malaria parasite Plasmodium yoelii (PyMiGS) plays a critical role in male osmiophilic body formation and exflagellation.PV1, a novel Plasmodium falciparum merozoite dense granule protein, interacts with exported protein in infected erythrocytes.
P2860
Q26772878-5715797F-388B-4C00-AD5F-4B3352960461Q27230016-78D22E74-B611-4C85-829B-BF084A63D2C4Q27681425-38B2B941-00F8-4904-9124-CDD782D020E0Q27972840-2615D6A9-30E8-4E4F-A660-99BE4D28FEF3Q27973701-2A797DC3-0923-4270-82E6-760F06A8BDECQ30044113-DFAEFA92-D1E5-4DC4-9717-0BD557B99795Q30047043-160C88E1-2E88-4CAF-BA24-3670C5AD7EAFQ33617694-AE54183B-B0CA-4A29-97CE-1B0EBA3BB983Q35619023-BDF409CB-462D-4C87-9E15-2861A03A408BQ35642087-DA5949B7-B8FF-4587-979A-0ED9E59E2EEAQ35877857-E4405E98-1DFD-46A7-87D5-4B937D35FD58Q36384456-B205B44C-86C3-4B6F-BC48-B638B4DB820BQ36413834-FD320D76-704E-4AD2-887E-EB61C3F5622FQ36826946-AF3D1100-6910-49B2-8DC9-090E8EB266EDQ36891280-75431684-9810-40D8-971C-5E4A5EE03447Q36950470-8223698C-D5C2-4FDC-B505-DB5B524590A8Q36984161-1D50029D-8F27-4DE8-9026-0342486E2D65Q37025030-6EFAA8BF-C1B9-4F75-85A7-01BC1800CBB4Q37264788-1004CF75-03E6-4373-A28C-3196A3482B45Q37336089-B300324D-77D9-4D10-A529-A884888C5936Q37349102-AB4C4F5D-7211-47A6-8BF3-D48890F74A5BQ37357825-17DC6EAB-A5B6-41CB-9440-000966E37985Q38168906-A18C7456-15D2-4930-8CB3-EB62D0DF31D4Q38672088-1DA3B2C7-42FD-4226-BCB4-CA5798CA7C91Q38943177-E4A39414-BB46-476F-BCF5-3B3D380DB6C6Q41821299-7BAD4E02-EA6C-43F1-8046-4343CDA75C59Q42254570-4F6889D6-2CE7-4C64-84D1-E205F3D29571Q47217736-186F8594-2244-4F68-AE42-4D4DD66607BBQ52371941-3B57CBC9-07C8-472D-8E18-098E8AF70EC4
P2860
Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Discovery of GAMA, a Plasmodiu ...... age vaccine candidate antigen.
@ast
Discovery of GAMA, a Plasmodiu ...... age vaccine candidate antigen.
@en
type
label
Discovery of GAMA, a Plasmodiu ...... age vaccine candidate antigen.
@ast
Discovery of GAMA, a Plasmodiu ...... age vaccine candidate antigen.
@en
prefLabel
Discovery of GAMA, a Plasmodiu ...... age vaccine candidate antigen.
@ast
Discovery of GAMA, a Plasmodiu ...... age vaccine candidate antigen.
@en
P2093
P2860
P50
P356
P1476
Discovery of GAMA, a Plasmodiu ...... age vaccine candidate antigen.
@en
P2093
Amporn Thonkukiatkul
Hitoshi Otsuki
Jennifer Thompson
Julie Healer
Motomi Torii
Satoru Takeo
Thangavelu U Arumugam
Tsutomu Yamasaki
P2860
P304
P356
10.1128/IAI.05412-11
P407
P50
P577
2011-09-06T00:00:00Z